Senate Resolution by Senator Rodriguez designates the week of May 3, 2026, as Tardive Dyskinesia Awareness Week in Florida. The resolution highlights the increasing use of antipsychotic medications for treating serious mental illnesses such as bipolar disorder, major depressive disorder, and schizophrenia, which can lead to tardive dyskinesia (TD). TD is characterized by uncontrollable and repetitive movements and affects a significant number of individuals, particularly those over 55, women, and those with certain mental health conditions. Alarmingly, around 60% of the estimated 800,000 adults in the U.S. living with TD remain undiagnosed, emphasizing the need for early screening and intervention.

The resolution underscores the importance of routine TD screenings as recommended by the American Psychiatric Association and encourages individuals on antipsychotic medications to consult healthcare providers for assessment and management of TD risk. It also advocates for increased education and awareness among healthcare providers, patients, and caregivers to ensure that those prescribed antipsychotics receive appropriate care, including regular screenings. By recognizing Tardive Dyskinesia Awareness Week, the Senate aims to promote understanding of the condition and improve the quality of life for those affected.